Management of Advanced Non–Small-Cell Lung Cancer in Patients with a Performance Status of 2-Reference-Cited by-同舟云学术

Management of Advanced Non–Small-Cell Lung Cancer in Patients with a Performance Status of 2

Published:2004-01 Issue:4 Volume:5 Page:209-213
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Lilenbaum Rogerio

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference20 articles.

1. Single-agent versus combination chemotherapy in advanced non-small cell lung cancer: a CALGB randomized trial of efficacy, quality of life, and cost-effectiveness;Lilenbaum;Proc Am Soc Clin Oncol,2002

2. The clinical evaluation of chemotherapeutic agents in cancer;Karnofsky,1949

3. Prognostic factors for survival in patients with inoperable lung cancer;Stanley;J Natl Cancer Inst,1980

4. A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer;Ruckdeschel;J Clin Oncol,1986

5. Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience;Albain;J Clin Oncol,1991

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of Upper Gastrointestinal Symptoms and Their Influence on Nutritional State and Performance Status in Patients With Different Primary Tumors Receiving Palliative Care;American Journal of Hospice and Palliative Medicine®;2013-01-24

2. Topotecan Therapy in Patients with Relapsed Small-Cell Lung Cancer and Poor Performance Status;Clinical Lung Cancer;2006-09

3. Impact of a Palliative Care Service on In-Hospital Mortality in a Comprehensive Cancer Center;Journal of Palliative Medicine;2006-08

4. Topotecan in the Treatment of Elderly Patients with Relapsed Small-Cell Lung Cancer;Clinical Lung Cancer;2005-11

5. Clinical Pharmacology Issues Relevant to the Dosing and Toxicity of Chemotherapy Drugs in the Elderly;The Oncologist;2005-09-01